Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
157.60    3.80 (2.47%)
Bid:
157.60
Ask:
158.00
Spread: 0.40 (0.254%)
Market Cap: £385.03m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Trading Update

13 Oct 2022 07:00

RNS Number : 7077C
Sabre Insurance Group PLC
13 October 2022
 

13 October 2022

 

Sabre Insurance Group plc

 

Trading Update

Guidance for the Full Year reiterated

 

Sabre Insurance Group plc (the "Group" or "Sabre"), one of the UK's leading motor insurance underwriters, today provides an update on trading for the period from 1 July 2022 to 30 September 2022.

Geoff Carter, Chief Executive Officer of Sabre, commented:

"I am pleased with the resilience of our performance through to the end of the third quarter. We have continued to focus on both margin over volume and fully covering the ongoing high levels of claims inflation through price increases that are significantly higher than the market. This consistent strategy ensures that Sabre remains on a sound financial and operational footing for the times ahead. 

It is encouraging that despite our above-market price increases we are still delivering volumes in line with our expectations. It is pleasing that we are seeing the planned improvement in our Motor loss ratio.

We have benefitted from writing more Motorcycle business than planned which will generate some natural first year growth strain. As this growth strain subsides the volumes written in our Motorcycle and Taxi businesses will make attractive ongoing profit contributions as our pricing discipline and underwriting initiatives flow through.

The resilience of our Motor performance, and future profit streams from Motorcycle and Taxi, mean that despite the ongoing macro and geo-political uncertainties, we are looking forward with confidence as our specialist offering and discipline over the recent challenging periods pays dividends."

Financial highlights

Unaudited

Unaudited

Audited

9 months ended

9 months ended

12 months ended

 30 Sept 2022

30 Sept 2021

31 December 2021

Gross written premium

£135.7m

£126.7m

£169.3m

Gross written premium - Motor

£105.2m

£125.5m

£164.6m*

Gross written premium - Motorcycle

£20.9m

£Nil

£3.2m

Gross written premium - Taxi

£9.6m

£1.2m

£1.5m*

Post-dividend solvency capital ratio

163%

175%

164%

 *Motor and Taxi split not previously disclosed and split not audited

Navigating the inflationary environment

Our analysis suggests that the broader market rate increases reported for the year to date are between 10% and 11%, with approximately half of this market rate rise in response to the new FCA pricing rules and half of the market rate rise a direct response to claims inflation. 

However, we believe that claims inflation itself is currently running at approximately 12%, meaning that we continue to anticipate a market-wide correction through the final quarter of the year and the first quarter of next year. There are some early signs of an acceleration of price increase by many competitors in recent weeks.

In response to this inflationary environment - and in contrast to the broader market - Sabre has continued to increase prices to reflect claims inflation fully, increasing Motor policy prices by 24% to the end of September 2022, and by 31% over the past twelve months. Our volumes continue to be in line with expectation.

Consequently, we reiterate our guidance for the Full Year and anticipate a combined operating ratio in the mid-90%'s that we expect will improve significantly in 2023. 

Long term confidence

Sabre has a strong market position within its Motor business and has proven through this cycle its ability to mitigate inflation with price increases. Sabre's diversification into the complementary Motorcycle and Taxi businesses has created new areas of specialist growth and will make profitable contributions going forward. 

This strategy is underpinned by a well-funded balance sheet, with no debt, and with a strong ongoing solvency capital position, above our target range of 140% to 160%. Additionally, Sabre's investment portfolio is low risk and operates a matching policy to ensure that movements in interest/risk-free rates have a minimal impact on its solvency position. 

The Board remains very confident in the long-term prospects of the business.

 

Investor enquiries

01306 747 272

Sabre Insurance Group plc

investor.relations@sabre.co.uk

Geoff Carter / Adam Westwood

Media enquiries

020 7353 4200

Tulchan Communications

sabre@tulchangroup.com

James Macey White / Guy Bates

 

LEI Code: 2138006RXRQ8P8VKGV98

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFLFMEEESEDS
Date   Source Headline
2nd Jun 20267:00 amRNSOn-market Share Buyback Programme of £5m
27th May 20269:36 amRNSDirector Declaration
21st May 202611:20 amRNSResult of AGM
21st May 20267:00 amRNSTrading Update
12th May 20261:22 pmRNSDirector/PDMR Shareholding
22nd Apr 20261:18 pmRNSDirector/PDMR Shareholding
14th Apr 20263:48 pmRNSDirector/PDMR Shareholding
13th Apr 20263:18 pmRNSDirector/PDMR Shareholding
8th Apr 20262:56 pmRNSDirector/PDMR Shareholding
8th Apr 202610:41 amRNSDirector/PDMR Shareholding
8th Apr 202610:39 amRNSDirector/PDMR Shareholding
30th Mar 202611:01 amRNSNotice of AGM
11th Mar 20261:49 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSFull-year results 2025
11th Feb 20261:27 pmRNSDirector/PDMR Shareholding
13th Jan 20263:43 pmRNSDirector/PDMR Shareholding
11th Dec 20251:29 pmRNSDirector/PDMR Shareholding
11th Nov 20251:40 pmRNSDirector/PDMR Shareholding
31st Oct 20258:00 amRNSTotal Voting Rights
23rd Oct 20259:58 amRNSDirector/PDMR Shareholding
16th Oct 20257:00 amRNSTrading Update
14th Oct 20257:49 amRNSHolding(s) in Company
13th Oct 20253:56 pmRNSDirector/PDMR Shareholding
3rd Oct 20257:00 amRNSCompletion of Buyback Programme
3rd Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 20257:00 amRNSTransaction in Own Shares
30th Sep 202510:21 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20251:01 pmRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20254:52 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 202512:24 pmRNSDirector/PDMR Shareholding
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.